80 related articles for article (PubMed ID: 7804568)
21. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
Broen JB; Bradley DS; Powell KM; Cafruny WA
Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
[TBL] [Abstract][Full Text] [Related]
22. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
Monteyne P; Coutelier JP
J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immunity in cervical cancer evolution.
Jandová A; Pokorný J; Kobilková J; Janousek M; Masata J; Trojan S; Nedbalová M; Dohnalová A; Beková A; Slavík V; Cocek A; Sanitrák J
Electromagn Biol Med; 2009; 28(1):1-14. PubMed ID: 19337890
[TBL] [Abstract][Full Text] [Related]
24. [The use of high effectiveness gel chromatography in the preparation of antigen for the LAI test in gynecological neoplasms].
Jandová A; Heyberger K; Motycka K; Roubal J; Sanitrák J; Coupek J; Trnka V
Cesk Gynekol; 1979 Dec; 44(10):742-4. PubMed ID: 396994
[No Abstract] [Full Text] [Related]
25. [Value of LAI test in immunodiagnosis of gynecologic tumors (author's transl)].
Trnka V; Heyberger K; Jandová A
Bratisl Lek Listy; 1979 Sep; 72(3):280-3. PubMed ID: 389362
[No Abstract] [Full Text] [Related]
26. Lactate dehydrogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants.
Weiland E; Grossmann A; Thiel HJ; Weiland F
J Gen Virol; 1990 May; 71 ( Pt 5)():1233-6. PubMed ID: 2345370
[TBL] [Abstract][Full Text] [Related]
27. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity.
Isakov N; Feldman M; Segal S
Immunobiology; 1982; 162(1):15-27. PubMed ID: 7106838
[TBL] [Abstract][Full Text] [Related]
28. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes.
Isakov N; Segal S
Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999
[TBL] [Abstract][Full Text] [Related]
29. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection.
Michaelides MC; Simms ES
Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506
[TBL] [Abstract][Full Text] [Related]
30. [Value of MS associated factors for test procedures in multiple sclerosis: 2. Angers' MS-induced substance in the LAI test].
Lehmitz R; Meyer U; Meyer-Rienecker HJ
Psychiatr Neurol Med Psychol (Leipz); 1983 Dec; 35(12):714-9. PubMed ID: 6366844
[TBL] [Abstract][Full Text] [Related]
31. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
Chen Z; Li K; Plagemann PG
Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
[TBL] [Abstract][Full Text] [Related]
32. [Immunobiological examination of psychiatric patients. Preliminary report (author's transl)].
Dvoráková M; Jandová A; Mejsnarová B; Vinglerová M; Zvolsky P; Heyberger K; Motycka K; Coupek J
Sb Lek; 1981; 83(11-12):337-41. PubMed ID: 7034146
[No Abstract] [Full Text] [Related]
33. Characterization of lactate dehydrogenase-elevating virus ORF6 protein expressed by recombinant baculoviruses.
Takahashi-Omoe H; Omoe K; Matsushita S; Inada T
Comp Immunol Microbiol Infect Dis; 2004 Nov; 27(6):423-31. PubMed ID: 15325515
[TBL] [Abstract][Full Text] [Related]
34. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
35. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
Sasaki Y; Hayashi T; Hasegawa K
Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
[TBL] [Abstract][Full Text] [Related]
36. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
[TBL] [Abstract][Full Text] [Related]
37. Changes of leukocyte adherence ability under the influence of magnetic field in the course of a treatment of patients with laryngeal and pharyngeal carcinoma.
Cocek A; Hahn A; Ambrus M; Dohnalová A; Jandová A; Pokorný J
Electromagn Biol Med; 2008; 27(3):277-88. PubMed ID: 18821203
[TBL] [Abstract][Full Text] [Related]
38. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
McDonald TL; Donnelly T; Weber A; Quenette L
Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
[TBL] [Abstract][Full Text] [Related]
39. The murine antibody response to lactate dehydrogenase-elevating virus.
Coutelier JP; Van Roost E; Lambotte P; Van Snick J
J Gen Virol; 1986 Jun; 67 ( Pt 6)():1099-108. PubMed ID: 3519860
[TBL] [Abstract][Full Text] [Related]
40. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
Cafruny WA; Bradley SE
J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
